FRTX insider filings
Fresh Tracks Therapeutics, Inc. — 30 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-11. Screen FRTX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for FRTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Fresh Tracks Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-11 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 319,315 @ $0.94 · Purchase (P): 86,185 @ $0.94 | EDGAR |
| 2024-05-31 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 80 @ $0.87 · Purchase (P): 9,838 @ $0.92 · Purchase (P): 516 @ $0.89 | EDGAR |
| 2024-05-23 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 6,879 @ $0.91 · Purchase (P): 383 @ $0.89 · Purchase (P): 15,627 @ $0.91 | EDGAR |
| 2024-05-20 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 73,768 @ $0.92 · Purchase (P): 797 @ $0.91 | EDGAR |
| 2024-05-08 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 320 @ $0.89 | EDGAR |
| 2024-05-03 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 162,351 @ $0.92 · Purchase (P): 2,222 @ $0.91 · Purchase (P): 324 @ $0.91 | EDGAR |
| 2024-04-23 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 4,277 @ $0.91 · Purchase (P): 16,908 @ $0.90 · Purchase (P): 343 @ $0.91 | EDGAR |
| 2024-04-11 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 2,188 @ $0.88 · Purchase (P): 1,000 @ $0.88 | EDGAR |
| 2024-04-05 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 12,928 @ $0.91 · Purchase (P): 3,400 @ $0.91 · Purchase (P): 1,050 @ $0.91 | EDGAR |
| 2024-04-01 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 51,634 @ $0.90 · Purchase (P): 2,586 @ $0.90 · Purchase (P): 354 @ $0.89 | EDGAR |
| 2024-03-21 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 10 @ $0.90 · Purchase (P): 287 @ $0.91 | EDGAR |
| 2024-03-13 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 5,703 @ $0.91 · Purchase (P): 1,500 @ $0.91 · Purchase (P): 9,126 @ $0.92 | EDGAR |
| 2024-02-28 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 20,109 @ $0.90 | EDGAR |
| 2024-02-22 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 49,951 @ $0.88 · Purchase (P): 22,278 @ $0.90 · Purchase (P): 5,175 @ $0.90 | EDGAR |
| 2024-01-17 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 10,958 @ $0.98 · Purchase (P): 9,038 @ $0.99 | EDGAR |
| 2024-01-11 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 38,017 @ $0.98 · Purchase (P): 9,646 @ $0.98 · Purchase (P): 3,839 @ $0.98 | EDGAR |
| 2024-01-09 | 4 | Fox-Collis Aaron — VP of Finance & CAO | Disposition to issuer (D): 8,000 (derivative) @ $0.91 | EDGAR |
| 2024-01-09 | 4 | Marchio Albert N II — CEO and CFO, Director | Disposition to issuer (D): 1,250 (derivative) @ $0.91 | EDGAR |
| 2024-01-05 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 23,877 @ $0.89 · Purchase (P): 54,625 @ $0.90 | EDGAR |
| 2023-12-20 | 4 | Exploration Capital, LLC — 10% owner | Purchase (P): 47,000 @ $0.84 | EDGAR |
| 2023-12-11 | 4 | Fox-Collis Aaron — VP of Finance & CAO | Sale (S): 74 @ $0.91 | EDGAR |
| 2023-12-11 | 4 | Chadha Deepak — Former Chief R&D Officer & COO | Option exercise (M): 35,000 · Tax withholding (F): 14,978 @ $0.62 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2023-12-06 | 4 | Exploration Capital Fund, LP — 10% owner Exploration Capital, LLC — 10% owner Exploration Capital General Partner, LLC — 10% owner | Purchase (P): 7,579 @ $0.85 · Purchase (P): 5,188 @ $0.85 · Purchase (P): 17,233 @ $0.90 | EDGAR |
| 2023-12-04 | 4 | Fox-Colis Aaron — VP of Finance & CAO | Sale (S): 36.44 @ $0.85 | EDGAR |
| 2023-10-04 | 4 | Sklawer Andrew D — President and CEO | Option exercise (M): 55,000 · Tax withholding (F): 20,833 @ $0.98 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | McAvoy David R. — Gen Counsel, CCO, & Secretary | Option exercise (M): 20,000 · Tax withholding (F): 7,358 @ $0.98 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Chadha Deepak — Chief R&D Officer and COO | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Sklawer Andrew D — President | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | McAvoy David R. — Gen Counsel, CCO, & Secretary | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | MARCHIO ALBERT N II — Chief Financial Officer | Grant/award (A): 1,250 (derivative) @ $0 | EDGAR |
Recent 8-K events — Fresh Tracks Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-03 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-27 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs